Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-25 @ 5:14 PM
Study NCT ID:
NCT04186403
Status:
COMPLETED
Last Update Posted:
2024-10-03
First Post:
2019-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-02
First Submit QC Date:
None
Study First Post Date:
2019-12-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-09
Results First Submit QC Date:
None
Results First Post Date:
2024-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-09-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-10-03
Last Update Post Date Type:
ACTUAL